Literature DB >> 18761811

Intracellular signals of T cell costimulation.

Jianxun Song1, Fengyang Tylan Lei, Xiaofang Xiong, Rizwanul Haque.   

Abstract

Ligation of T cell receptor (TCR) alone is insufficient to induce full activation of T lymphocytes. Additional ligand-receptor interactions (costimulation) on antigen presenting cells (APCs) and T cells are required. T cell costimulation has been shown to be essential for eliciting efficient T cell responses, involving all phases during T cell development. However, the mechanisms by which costimulation affects the function of T cells still need to be elucidated. In recent years, advances have been made in studies of costimulation as potential therapies in cancer, infectious disease as well as autoimmune disease. In this review, we discussed intracellular costimulation signals that regulate T cell proliferation, cell cycle progression, cytokine production, survival, and memory development. In general, the pathway of phosphoinositide-3 kinase (PI3K)/protein kinase B (PKB, also known as Akt)/nuclear factor kappaB (NF-kappaB) might be central to many costimulatory effects. Through these pathways, costimulation controls T-cell expansion and proliferation by maintenance of survivin and aurora B expression, and sustains long-term T-cell survival and memory development by regulating the expression of bcl-2 family members.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18761811      PMCID: PMC4651295          DOI: 10.1038/cmi.2008.30

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  28 in total

Review 1.  Costimulatory and coinhibitory receptors in anti-tumor immunity.

Authors:  Gregory Driessens; Justin Kline; Thomas F Gajewski
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

2.  Red blood cells carry out T cell growth and survival bioactivities that are sensitive to cyclosporine A.

Authors:  Ricardo F Antunes; Cláudia Brandão; Gonçalo Carvalho; Cristina Girão; Fernando A Arosa
Journal:  Cell Mol Life Sci       Date:  2009-10       Impact factor: 9.261

3.  Dendritic cell expression of ADAM23 governs T cell proliferation and cytokine production through the α(v)β(3) integrin receptor.

Authors:  D M Elizondo; T E Andargie; K M Marshall; A M Zariwala; M W Lipscomb
Journal:  J Leukoc Biol       Date:  2016-06-17       Impact factor: 4.962

4.  Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension.

Authors:  Antony Vinh; Wei Chen; Yelena Blinder; Daiana Weiss; W Robert Taylor; Jörg J Goronzy; Cornelia M Weyand; David G Harrison; Tomasz J Guzik
Journal:  Circulation       Date:  2010-11-29       Impact factor: 29.690

5.  Vitamin C supplementation reconstitutes polyfunctional T cells in streptozotocin-induced diabetic rats.

Authors:  Gamal Badr; Samir Bashandy; Hossam Ebaid; Mohamed Mohany; Douaa Sayed
Journal:  Eur J Nutr       Date:  2011-02-25       Impact factor: 5.614

6.  IFN-γ upregulates survivin and Ifi202 expression to induce survival and proliferation of tumor-specific T cells.

Authors:  Mary Zimmerman; Dafeng Yang; Xiaolin Hu; Feiyan Liu; Nagendra Singh; Darren Browning; Vadivel Ganapathy; Phillip Chandler; Divaker Choubey; Scott I Abrams; Kebin Liu
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

7.  Disparate roles for STAT5 in primary and secondary CTL responses.

Authors:  Diana M Mitchell; Matthew A Williams
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

Review 8.  Age-related defects in the cytoskeleton signaling pathways of CD4 T cells.

Authors:  Gonzalo G Garcia; Richard A Miller
Journal:  Ageing Res Rev       Date:  2009-11-24       Impact factor: 10.895

9.  The duration of T cell stimulation is a critical determinant of cell fate and plasticity.

Authors:  Natasa Miskov-Zivanov; Michael S Turner; Lawrence P Kane; Penelope A Morel; James R Faeder
Journal:  Sci Signal       Date:  2013-11-05       Impact factor: 8.192

10.  Selective inhibition of regulatory T cells by targeting the PI3K-Akt pathway.

Authors:  Rasha Abu-Eid; Raed N Samara; Laurent Ozbun; Maher Y Abdalla; Jay A Berzofsky; Kevin M Friedman; Mikayel Mkrtichyan; Samir N Khleif
Journal:  Cancer Immunol Res       Date:  2014-07-30       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.